Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2013-04-24 | Dr. Echelard holds a Ph. D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). He has over 25 years of research and biopharmaceutical experience. |
| 2014-04-23 | Dr. Echelard holds a Ph. D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). He has over 25 years of research and biopharmaceutical experience. |
| 2015-04-24 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2016-04-29 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2017-04-28 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2018-04-30 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). He had a key role in the isolation and characterization of the Hedgehog genes. |
| 2019-04-30 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2020-04-29 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2021-04-30 | Dr. Echelard holds a Ph.D. from Université de Montréal, and has completed post-doctoral studies at the Ludwig Institute of Cancer Research in Montreal (McGill University). |
| 2022-04-29 | Dr. Echelard holds a Ph.D. from Université de Montréal and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). Based on Mr. Echelard’s biotechnology and pharmaceutical industry experience, as well as his extensive management experience, the Board of Directors believes that Dr. Echelard has the appropriate set of skills to serve as a member of the Board. |
| 2023-05-01 | Dr. Echelard holds a Ph.D. from Université de Montréal and has completed post-doctoral studies at Ludwig Institute of Cancer Research in Montreal (McGill University). He has over 30 years of research and biopharmaceutical experience. |
| 2024-04-29 | Dr. Echelard has over 30 years of research and biopharmaceutical experience, including leadership roles in research and development and corporate and technology development. |
Data sourced from SEC filings. Last updated: 2025-10-11